Dr Farasat Bokhari
Phone: +44 (0)1603 59 7534 Location:
Farasat Bokhari is a Senior Lecturer (Associate Professor) in the School of Economics and Centre for Competition Policy at the University of East Anglia. He received his Ph.D. in Public Policy and Management from the Heinz School at Carnegie Mellon University, USA. Dr. Bokhari has taught at King’s College London (Lecturer, Department of Primary Care and Public Health Sciences), and Florida State University (Assistant Professor, Department of Economics), and was a post-doctoral fellow at the University of California, Berkeley (School of Public Health).
A health economist with a background in applied microeconomics, industrial organization, and a specialization in health policy, Dr. Bokhari’s research interests include competition, antitrust, and technologies in hospital and pharmaceutical industries. He also works in areas of outcomes research and research methods in health care. His research has looked at the evolution of industrial structures, innovation, the adoption and diffusion of health care technologies, managed care, economic and policy analysis of Attention Deficit/Hyper Activity Disorder (ADHD) and the market for psychostimulant drugs. His current work focuses on the valuation of new pharmaceutical products used in the treatment of ADHD, including generics and second generation drugs (`me-too' drugs) as well as their associated regulatory and market mechanisms (pay-to-delay, parallel trade, etc.).
As an applied economist, Dr. Bokhari has expertise working with large datasets. He has used American Hospital Association datasets to explain how the degree of competition among hospitals, relative to the degree of competition among managed care organizations in local markets, effects bargaining between these organizations, the profitability of hospitals and ultimately the adoption and diffusion of new technologies among hospitals. He has also collected, linked and maintained large datasets on the utilization of therapeutically equivalent pharmaceutical products for the treatment of ADHD, and used these to develop and estimate models of demand and substitution patterns among various choices.
His research has been published by leading academic journals including The Journal of Competition Law and Economics, The Journal of Industrial Economics, The International Journal of Industrial Organization, The Journal of Health Economics, and Health Economics.
Selective admission into stroke unit and patient outcomes: a tale of four citiesFull Text UEA Repository
Entry in the ADHD drugs market: Welfare impact of generics and me-toosFull Text UEA Repository
What is the price of pay-to-delay deals?Full Text UEA Repository
School accountability laws and consumption of psychostimulantsFull Text UEA Repository
Managed Care and the adoption of technology: The case of cardiac catheterizationFull Text UEA Repository
Risk factors for discontinuing drug therapy among children with ADHDFull Text UEA Repository
Open versus closed firms and the dynamics of industry evolutionFull Text UEA Repository
Government health expenditures and health outcomesFull Text UEA Repository
Attention-deficit/hyperactivity disorder in children: Excess costs before and after initial diagnosis and treatmentFull Text UEA Repository
Improving health outcomesFull Text UEA Repository
An analysis of the significant variation in psychostimulant use across the U.SFull Text UEA Repository
Key Research Interests
Areas of Expertise
Econometric theory, methods, and practice
Healthcare and Pharmaceuticals (USA and Europe)